Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Milestone Scientific (MLSS) Shares Outstanding (Diluted Average) (2016 - 2025)

Milestone Scientific's Shares Outstanding (Diluted Average) history spans 15 years, with the latest figure at $82.0 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Diluted Average) rose 2.3% year-over-year to $82.0 million; the TTM value through Sep 2025 reached $82.0 million, up 2.3%, while the annual FY2021 figure was $68.8 million, 9.15% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q3 2025 was $82.0 million at Milestone Scientific, up from $80.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $82.0 million in Q3 2025 and bottomed at $66.6 million in Q1 2021.
  • The 5-year median for Shares Outstanding (Diluted Average) is $70.4 million (2022), against an average of $72.5 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) soared 33.88% in 2021 before it increased 1.64% in 2022.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $68.8 million in 2021, then increased by 3.12% to $71.0 million in 2022, then increased by 1.51% to $72.0 million in 2023, then rose by 11.27% to $80.2 million in 2024, then increased by 2.3% to $82.0 million in 2025.
  • Per Business Quant, the three most recent readings for MLSS's Shares Outstanding (Diluted Average) are $82.0 million (Q3 2025), $80.2 million (Q3 2024), and $80.0 million (Q2 2024).